Cargando…

Aberrant Promoter Hypermethylation of RASSF Family Members in Merkel Cell Carcinoma

Merkel cell carcinoma (MCC) is one of the most aggressive cancers of the skin. RASSFs are a family of tumor suppressors that are frequently inactivated by promoter hypermethylation in various cancers. We studied CpG island promoter hypermethylation in MCC of RASSF2, RASSF5A, RASSF5C and RASSF10 by c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Richter, Antje M., Haag, Tanja, Walesch, Sara, Herrmann-Trost, Peter, Marsch, Wolfgang C., Kutzner, Heinz, Helmbold, Peter, Dammann, Reinhard H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875954/ https://www.ncbi.nlm.nih.gov/pubmed/24252868 http://dx.doi.org/10.3390/cancers5041566

Ejemplares similares

Claudin11 Promoter Hypermethylation Is Frequent in Malignant Melanoma of the Skin, but Uncommon in Nevus Cell Nevi
por: Walesch, Sara K., et al.
Publicado: (2015)

Aberrant Promoter Methylation of the Tumour Suppressor RASSF10 and Its Growth Inhibitory Function in Breast Cancer
por: Richter, Antje M., et al.
Publicado: (2016)

The apoptosis associated tyrosine kinase gene is frequently hypermethylated in human cancer and is regulated by epigenetic mechanisms
por: Haag, Tanja, et al.
Publicado: (2014)

Promoter Methylation Status of Ras-Association Domain Family Members in Pheochromocytoma
por: Richter, Antje M., et al.
Publicado: (2015)

RASSF10 is frequently epigenetically inactivated in kidney cancer and its knockout promotes neoplasia in cancer prone mice
por: Richter, Antje M., et al.
Publicado: (2020)

The dual specificity phosphatase 2 gene is hypermethylated in human cancer and regulated by epigenetic mechanisms
por: Haag, Tanja, et al.
Publicado: (2016)

The tumor suppressor RASSF10 is upregulated upon contact inhibition and frequently epigenetically silenced in cancer
por: Richter, A M, et al.
Publicado: (2012)

RASSF10 Is a TGFβ-Target That Regulates ASPP2 and E-Cadherin Expression and Acts as Tumor Suppressor That Is Epigenetically Downregulated in Advanced Cancer
por: Richter, Antje M., et al.
Publicado: (2019)

The SARAH Domain of RASSF1A and Its Tumor Suppressor Function
por: Dittfeld, Claudia, et al.
Publicado: (2012)

Frequent epigenetic inactivation of RASSF2 in thyroid cancer and functional consequences
por: Schagdarsurengin, Undraga, et al.
Publicado: (2010)

Impact of Natural Compounds on DNA Methylation Levels of the Tumor Suppressor Gene RASSF1A in Cancer
por: Dammann, Reinhard H., et al.
Publicado: (2017)

The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma
por: Djos, Anna, et al.
Publicado: (2012)

Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma
por: Lázcoz, Paula, et al.
Publicado: (2006)

Silencing of RASSF3 by DNA Hypermethylation Is Associated with Tumorigenesis in Somatotroph Adenomas
por: Peng, Hu, et al.
Publicado: (2013)

Differential involvement of RASSF2 hypermethylation in breast cancer subtypes and their prognosis
por: Perez-Janices, Noemi, et al.
Publicado: (2015)

The tumor suppressor RASSF1A induces the YAP1 target gene ANKRD1 that is epigenetically inactivated in human cancers and inhibits tumor growth
por: Jiménez, Adriana P., et al.
Publicado: (2017)

Identification of RASSF1A promoter hypermethylation as a biomarker for hepatocellular carcinoma
por: Xu, Gang, et al.
Publicado: (2020)

Aberrant Promoter Hypermethylation of RASSF1a and BRCA1 in Circulating Cell-Free Tumor DNA Serves as a Biomarker of Ovarian Carcinoma
por: S, Sandeep Kumar, et al.
Publicado: (2019)

Deciphering Promoter Hypermethylation of Genes Encoding for RASSF/Hippo Pathway Reveals the Poor Prognostic Factor of RASSF2 Gene Silencing in Colon Cancers
por: Riffet, Marc, et al.
Publicado: (2021)

Frequent Promoter Hypermethylation of the APC and RASSF1A Tumour Suppressors in Parathyroid Tumours
por: Juhlin, C. Christofer, et al.
Publicado: (2010)

Circulating Hypermethylated RASSF1A as a Molecular Biomarker for Diagnosis of Hepatocellular Carcinoma
por: Mansour, Lamiaa A, et al.
Publicado: (2017)

Hypermethylated RASSF1A as Circulating Tumor DNA Marker for Disease Monitoring in Neuroblastoma
por: van Zogchel, Lieke M. J., et al.
Publicado: (2020)

RASSF1A hypermethylation in pretreatment serum DNA of neuroblastoma patients: a prognostic marker
por: Misawa, A, et al.
Publicado: (2009)

Detection and monitoring of hypermethylated RASSF1A in serum from patients with metastatic breast cancer
por: Kristiansen, Søren, et al.
Publicado: (2016)

RASSF2, a potential tumour suppressor, is silenced by CpG island hypermethylation in gastric cancer
por: Endoh, M, et al.
Publicado: (2005)

Frequent DNA Hypermethylation at the RASSF1A and APC Gene Loci in Prostate Cancer Patients of Pakistani Origin
por: Yaqinuddin, Ahmed, et al.
Publicado: (2013)

Danhong Injection Alleviates Cardiac Fibrosis via Preventing the Hypermethylation of Rasal1 and Rassf1 in TAC Mice
por: Li, Sinai, et al.
Publicado: (2020)

Novel Circulating Hypermethylated RASSF1A ddPCR for Liquid Biopsies in Patients With Pediatric Solid Tumors
por: van Zogchel, Lieke M. J., et al.
Publicado: (2021)

The Ras-association domain family (RASSF) members and their role in human tumourigenesis
por: van der Weyden, Louise, et al.
Publicado: (2007)

RASSF6; the Putative Tumor Suppressor of the RASSF Family
por: Iwasa, Hiroaki, et al.
Publicado: (2015)

Aberrant Methylation of RASSF1A Closely Associated with HNSCC, a Meta-Analysis
por: Meng, Rui-Wei, et al.
Publicado: (2016)

Aberrant expression of ALK and EZH2 in Merkel cell carcinoma
por: Veija, Tuukka, et al.
Publicado: (2017)

Promoter hypermethylation inactivates CDKN2A, CDKN2B and RASSF1A genes in sporadic parathyroid adenomas
por: Arya, Ashutosh Kumar, et al.
Publicado: (2017)

Promoter hypermethylation of the tumor-suppressor genes ITIH5, DKK3, and RASSF1A as novel biomarkers for blood-based breast cancer screening
por: Kloten, Vera, et al.
Publicado: (2013)

Vascular Endothelial Growth Factor Receptor-3 Expression Predicts Sentinel Node Status in Primary Cutaneous Melanoma
por: TOBERER, Ferdinand, et al.
Publicado: (2020)

RASSF1A hypermethylation is associated with ASXL1 mutation and indicates an adverse outcome in non-M3 acute myeloid leukemia
por: Liu, Fang, et al.
Publicado: (2017)

Aberrant CpG Islands Hypermethylation Profiles in Malignant Gliomas
por: Kim, Kwang Ryeol, et al.
Publicado: (2014)

HOXA11 gene is hypermethylation and aberrant expression in gastric cancer
por: Bai, Yinguo, et al.
Publicado: (2014)

The RASSF1 Gene and the Opposing Effects of the RASSF1A and RASSF1C Isoforms on Cell Proliferation and Apoptosis
por: Reeves, Mark E., et al.
Publicado: (2013)

Immunhistochemische Analyse einer Hypoxie-assoziierten Signatur in Melanomen mit positivem und negativem Schildwächterlymphknoten: Hypoxie-assoziierte Signatur primär kutaner Melanome
por: Toberer, Ferdinand, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_frfr6g5i2iia3bohr842e1kk04